Kinins pp 281-284 | Cite as

An Active Kallikrein-α2-Macroglobulin Complex Generated by Treatment of Human Plasma with Acetone

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 70)


Earlier functional studies on endogenous kinin formation in human plasma suggested that depending on the mode of treatment of the plasma, different kininogenases are activated predominantly: kininogenase I, activated by e.g. acid or acetone, acting on kininogen I; kininogenase II, activated by contact of plasma with glass, quartz etc., acting on kininogen II (Vogt, 1966). The existance of two kininogens, differing in molecular weight and affinity to plasma kallikrein, has meanwhile been well established. Kininogen II, highly sensitive to contact activated kininogenase(s), can be equated with high molecular weight kininogen (HMW-K), whereas kininogen I corresponds to low molecular weight kininogen (LMW-K) (Habal and Movat, 1972; Seidel, 1973; Habal et al., 1974). The existence of two kininogenases has been questioned however, since by fractionation of plasma other investigators found only one kinin-forming enzyme, plasma kallikrein — apart from the weakly active plasmin. Wendel et al. (1972) purified the contact-activated kininogenase (II) and found that it was not distinguishable in molecular size and isoelectric point from plasma kallikrein. The enzyme acted predominantly but not exclusively, on HMW-K (kininogen II). An attempt was therefore made to purify the acetone-activated enzyme (kininogenase I by the original definition) and to see whether it differs in its properties from the contact-activated enzyme.


Human Plasma Free Enzyme DEAE Cellulose Active Plasmin Plasma Kallikrein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bagdasarian, A., Lahiri, B., Talamo, R.C., Wong, P., Colman, R.W.: Immunochemical studies of plasma kallikrein. J.Clin.Invest. 54, 1444 (1974).PubMedCrossRefGoogle Scholar
  2. Habal, F.M., Movat, H.Z.: Kininogens of human plasma. Res. Comm. Chem. Path. Pharmacol. 4, 477 (1972).Google Scholar
  3. Habal, F.M., Movat, H.Z., Burrowed, C.E.: Isolation of two functionally different kininogens from human plasma — Separation from proteinase inhibitors and interaction with plasma kalli-krein. Biochem. Pharmacol. 23, 2291 (1974).PubMedCrossRefGoogle Scholar
  4. Harpel, P.C.: Human plasma α2-macroglobulin. An inhibitor of plasma kallikrein. J. exp. Med. 132, 329 (1970).PubMedCrossRefGoogle Scholar
  5. McConnell, D.J.: Inhibitors of kallikrein in human plasma. J. Clin. Invest. 51, 1611 (1972).PubMedCrossRefGoogle Scholar
  6. Seidel, G: Two functionally different kininogens in human plasma. Agents and Actions 3, 12 (1973).PubMedCrossRefGoogle Scholar
  7. Vogt, W.: Demonstration of the presence of two separate kinin-forming systems in human and other plasma. In: Hypotensive peptides, p. 185, ed. by E.G. Erdos, N. Back and F. Sicuteri, Berlin-Heidelberg-New York: Springer 1966.CrossRefGoogle Scholar
  8. Wendel, U., Vogt, W., Seidel, G.: Purification and some properties of a kininogenase from human plasma activated by surface contact. Hoppe-Seylers Z. physiol. Chem. 353, 1591 (1972).PubMedCrossRefGoogle Scholar
  9. Wuepper, K.D.: Biochemistry and biology of components of the plasma kinin-forming system. In: Inflammation mechanism and control, p. 93, ed. by I.H. Lepow and P.A. Ward. Academic Press, New York, 1972.Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • W. Vogt
    • 1
  1. 1.Department of Biochemical PharmacologyMax-Planck-Institut für experimentelle MedizinD-34 GottingenGermany

Personalised recommendations